MONTRÉAL, September 19, 2025 – No announcements have been made over the summer on progress in gaining access to two novel hemophilia therapies. Altuviiio for hemophilia A In June,...
While this does not affect Canada directly, it is a major step forward for the international community and acknowledges what Canada is already doing in terms of treatment. CLICK...
The call for applications for the CHS’ research programs for the 2026-2027 grant period is ongoing. The deadline to submit applications for all the programs is NOVEMBER 28, 2025. CLICK...
The CHS is very proud to present its latest publication, the first component of its brand-new Novel Therapies Education Program. CLICK HERE to access the online booklet.